Insights

Innovative Oncology Pipeline Aptose Biosciences is developing first-in-class targeted therapies such as CG-806 and APTO-253, which address unmet clinical needs in hematologic malignancies including AML, MDS, CLL, and NHL, presenting opportunities for collaborations in precision medicine and specialized oncology treatments.

Strategic Partnerships and Trials The company's collaborations with the National Cancer Institute and participation in prestigious clinical trials like EHA Congress highlight ongoing research and development efforts, offering potential avenues for partnership, licensing, and joint development initiatives to accelerate bringing therapies to market.

Recent Funding and Financials With recent equity facility investments and a public offering, Aptose is actively strengthening its financial position, making it open to outreach regarding strategic investments, licensing deals, or co-development opportunities for its innovative pipeline.

Market Expansion Potential Focused on hematologic cancers resistant to conventional treatments, Aptose’s therapies target niche, high-need patient populations which could present sales opportunities within specialized oncology markets and personalized medicine sectors.

Junior but Growing Team Operating with a small but agile team, Aptose's focus on advanced targeted therapies positions it as a potential partner for biotech firms, contract research organizations, or technology providers looking to expand into innovative cancer therapeutics.

Aptose Biosciences, Inc. Tech Stack

Aptose Biosciences, Inc. uses 8 technology products and services including Adobe, WordPress, RSS, and more. Explore Aptose Biosciences, Inc.'s tech stack below.

Adobe

Audio, Video, Graphics

WordPress

Content Management System

RSS

Content Management System

Hoefler&Co

Font Scripts

Modernizr

Javascript Libraries

PHP

Programming Languages

Piwik

System Analytics & Monitoring

Apache

Web Servers

Aptose Biosciences, Inc. Email Formats	Example	Percentage
FLast@aptose.com	JDoe@aptose.com	50%
FLast@aptose.com	JDoe@aptose.com	50%

Aptose Biosciences, Inc. Email Formats

Example

Percentage

FLast@aptose.com

JDoe@aptose.com

50%

FLast@aptose.com

JDoe@aptose.com

50%

Frequently Asked Questions

Where is Aptose Biosciences, Inc.'s headquarters located?

Aptose Biosciences, Inc.'s main headquarters is located at 5955 Airport Road Mississauga, Ontario L4V 1R9 CA. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Aptose Biosciences, Inc.'s phone number?

You can contact Aptose Biosciences, Inc.'s main corporate office by phone at

+1-416-798-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aptose Biosciences, Inc.'s official website and social media links?

Aptose Biosciences, Inc.'s official website is aptose.com and has social profiles on LinkedIn.

What is Aptose Biosciences, Inc.'s SIC code NAICS code?

Aptose Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aptose Biosciences, Inc. have currently?

As of October 2025, Aptose Biosciences, Inc. has approximately 30 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Vice President Operations: R. D.Senior Vice President - Chief Commercial Officer: P. L.Vice President, Regulatory Affairs: G. M.. Explore Aptose Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Aptose Biosciences, Inc. belong to?

Aptose Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Aptose Biosciences, Inc. use?

Aptose Biosciences, Inc.'s tech stack includes AdobeWordPressRSSHoefler&CoModernizrPHPPiwikApache.

What is Aptose Biosciences, Inc.'s email format?

Aptose Biosciences, Inc.'s email format typically follows the pattern of FLast@aptose.com. Find more Aptose Biosciences, Inc. email formats with LeadIQ.

When was Aptose Biosciences, Inc. founded?

Aptose Biosciences, Inc. was founded in 2014.

Aptose Biosciences, Inc.

Q: What is Aptose Biosciences, Inc.'s official website and social media links?

Aptose Biosciences, Inc.'s official website is aptose.com. Aptose Biosciences, Inc. has social profiles on LinkedIn.

Q: How many employees does Aptose Biosciences, Inc. have currently?

Aptose Biosciences, Inc. has approximately 30 employees.

Q: What technology does Aptose Biosciences, Inc. use?

Aptose Biosciences, Inc.'s tech stack includes Piwik, SAP, OWL Carousel, Microsoft SharePoint, WordPress.

Biotechnology ResearchOntario, Canada11-50 Employees

Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.

CG-806, our oral mutation-agnostic FLT3/BTK inhibitor, is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments. 

CG-806 is also being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML), including the emerging populations resistant to approved targeted therapies.

APTO-253, our first-in-class MYC Inhibitor, is being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Insights

Similar companies to Aptose Biosciences, Inc.

Relay Therapeutics

Deciphera Pharmaceuticals

Mirati Therapeutics

Gilead Sciences